Board of directors

Jesper Høiland

Chair of The Board

Education:
MSc and BSc, Copenhagen Business School.

Other assignments:
Strategic advisor to pharmaceutical and medical device companies, CEO and founder of Phramaco Consult Aps and chief of staff at Rani Therapeutics.

Other board assignments:
Member of the board of directors and the audit committee of ALK, member of the board at Flen Health Group S.A., Allerity Therapeutcs and Alva Therapeutics .

Shares and options:
6,719,108 Shares

Independent in relation to the company:
Yes

Independent in relation to major shareholders:
Yes

Chairman of The Board since 2024

Robert Molander

Education:
MBA in Marketing and Finance, Washington University in St. Louis, John M. Olin School of Business. Dual Bachelor’s degrees in Economics and International Studies, Miami University.

Experience:
Senior executive and advisor with over 25 years of experience in life science commercialization, primarily in the United States. Robert has held senior leadership roles at global pharmaceutical and life science companies including Novartis, Pfizer, Shionogi and Trialbee, with a focus on product launches, business development and the build-out of commercial organizations. He has previously served as Chief Commercial Officer of Infant Bacterial Therapeutics AB and Trialbee AB, and as a board member of Infant Bacterial Therapeutics AB.

Other current assignments:
Board member of Xspray Pharma AB and Biosergen AB. CEO of Stratfox Healthcare Group LLC.

Shares and options:
8,333,332 Shares

Independent in relation to the company:
Yes

Independent in relation to major shareholders:
Yes

Member of the Board since 2024

Diana Ferro

Education:
Holds an MBA from the University of Hamburg and various follow-on educations among them an exam in medical marketing from UCLA (the University of California Los Angeles).

Other assignments:
CEO at Medskin Solutions Dr Suwelack AG.

Other board assignments:
-

Shares and options:
Holder of 272,272 shares.
98,175 TO2

Independent in relation to the company:
Yes

Independent in relation to major shareholders:
Yes

Member of the Board since 2017

Anna Eriksrud

Education:
Bachelor of Science (BSc) in Business Administration and Economics, Uppsala University.

Other board assignments:
Chairman of the Board in Prosperum Vitae AB and Board member in AcuCort AB.

Shares and options:
278,000

Independent in relation to the company:
Yes

Independent in relation to major shareholders:
Yes

Member of the Board since 2025